Mirum Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Foster City, CA
MIRM chart
What traders are saying about $MIRM
Latest postsMirum Pharmaceuticals, Inc. news
- Mirum Pharmaceuticals (MIRM) Breaches Primary Endpoint in Phase 3 Hepatitis Delta Trial
GuruFocus ·
- Mirum Pharmaceuticals (MIRM) Reports Positive Phase 3 Brelovitug Data
Simply Wall St ·
- Mirum Pharmaceuticals meets AZURE-4 Phase 3 endpoint
Mugglehead Investment Magazine ·
- Form 8K Mirum Pharmaceuticals Inc For: 10 November By Investing.com
Investing.com Canada ·
- Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history
Yahoo Finance UK ·
- Mirum Pharmaceuticals Reports Positive Phase 3 Brelovitug Results
TipRanks ·
- MIRM: Mirum Pharmaceuticals Inc. filed SEC Form 8-K: Other Events
Quantisnow ·
- Mirum Pharmaceuticals Announces Primary Endpoint Met in AZURE-4 Phase 3 Study and Highlights Long-Term Brelovitug Data Presented at AASLD
Yahoo Finance ·
- Vir, A Gilead Rival, Shoots To Two-Year High On Its 'Clean Win' In Hepatitis D Treatment
Yahoo Finance ·
- Mirum Pharmaceuticals (MIRM) Expands No Cost Rare Disease Testing Beyond Cholestasis
Simply Wall St ·
- Weekly Recap: Raised sales guidance and AZURE-1 meets primary endpoint
TradingView ·
- Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
Mirum Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $521.3M | $336.9M | $186.4M | $77.1M |
| Net income | -$23.4M | -$87.9M | -$163.4M | -$135.7M |
| Diluted EPS | $-0.47 | $-1.85 | $-4.00 | $-4.02 |
| Total assets (year end) | $842.8M | $670.8M | $646.6M | $352.9M |
| Cash and equivalents (year end) | $296.7M | $222.5M | $286.3M | $28.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mirum Pharmaceuticals, Inc.
- Ticker
- MIRM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1759425
Frequently asked questions
What exchange is Mirum Pharmaceuticals, Inc. listed on?
Mirum Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol MIRM.
What industry is Mirum Pharmaceuticals, Inc. in?
Mirum Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mirum Pharmaceuticals, Inc. headquartered?
Mirum Pharmaceuticals, Inc.'s business address on file with the SEC is in Foster City, CA.
When does Mirum Pharmaceuticals, Inc.'s fiscal year end?
Mirum Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Mirum Pharmaceuticals, Inc. report?
Mirum Pharmaceuticals, Inc. reported $521.3M in revenue for calendar year 2025, according to its SEC filings.